Connection

Karel Kostev to Biomarkers

Back to Details
This is a "connection" page, showing publications Karel Kostev has written about Biomarkers.
Karel Kostev
Connection Strength
0.076
Biomarkers
  1. Differences in baseline characteristics between type 2 diabetes mellitus patients treated with dipeptidyl peptidase-4 inhibitors in randomized controlled trials and those receiving the same treatment in real-world settings?. Int J Clin Pharmacol Ther. 2018 Sep; 56(9):411-416.
    View in: PubMed
    Score: 0.035
  2. Regional differences in insulin therapy regimens in five European countries?. Int J Clin Pharmacol Ther. 2017 May; 55(5):403-408.
    View in: PubMed
    Score: 0.032
  3. Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statins. Clin Res Cardiol. 2018 May; 107(5):380-388.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.